Alastair Compston
|
Alastair Compston CBE, FRCP, FMedSci, FRS, |
|
|---|---|
Alastair Compston at the Royal Society admissions day in London for new fellows in 2016
|
|
| Born | 23 January 1948 |
| Fields | neurology |
| Institutions | |
| Alma mater |
|
| Thesis | Multiple sclerosis and the HLA system (1978) |
|
Website www |
|
(David) Alastair (Standish) Compston (born 23 January 1948)CBE, FRCP, FMedSci, FRS is Professor Emeritus of Neurology in the Department Of Clinical Neurosciences at the University of Cambridge and an Emeritus Fellow of Jesus College, Cambridge.
Compston was educated at Rugby School followed by Middlesex Hospital Medical School where he was awarded a Bachelor of Medicine, Bachelor of Surgery degree. He completed his PhD on multiple sclerosis and the Human Leukocyte Antigen (HLA) system at the University of London graduating in 1978.
Compston’s research focuses on the clinical science of human demyelinating disease including the discovery of genetic risk factors for multiple sclerosis and the introduction of alemtuzumab.
Compston was formerly Professor of Neurology at the University of Wales, president of the European Neurological Society and the Association of British Neurologists, and editor of the journal Brain.
Compston's work has been recognised by prizes including the Charcot Award; the K-J Zülch Prize; the World Federation of Neurology Medal; the John Dystel Prize; the Richard and Mary Cave Award of the Multiple Sclerosis Society of Great Britain; the Hughlings Jackson Medal; the Galen Medal; and the Association of British Neurologists Medal.
...
Wikipedia